BLFS — BIOLIFE SOLUTIONS INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 834365 ·
Last close
$38.61
Market Cap
$1.89B
52W High
$38.61
52W Low
$38.61
ADV30
0
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 28,466,000 | 18,287,000 | 1,696,000 | 45,104,000 | 447,494,000 | 23,997,000 | 27,491,000 |
| Mar 2026 | 27,500,000 | 17,496,000 | 27,000 | 1,186,000 | 400,906,000 | 22,822,000 | 28,676,000 |
| Dec 2025 | 18,785,000 | 11,977,000 | 1,347,000 | 11,070,000 | 405,884,000 | 33,038,000 | 33,996,000 |
| Sep 2025 | 28,067,000 | 17,921,000 | -89,000 | 621,000 | 392,081,000 | 29,481,000 | 38,342,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$17,897,000
Investing CF
$-46,193,000
Financing CF
$-15,827,000
CapEx
$-19,691,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.08
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-338,510,000
Inventory
$32,834,000
Receivables
$13,057,000
ST Investments
$58,174,000
EBIT TTM
$-15,358,000
Pretax Income TTM
$-10,399,000
Interest Exp TTM
—
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$106,688,000
EBITDA
$6,900,000
Free Cash Flow
$4,664,875
Enterprise Value
$1,642,611,328
Total Cash
$82,416,000
Total Debt
$15,738,000
Shares Out
48,923,333
Trailing EPS
$1.00
Book Value
$8.59
ROE
12.8%
ROA
0.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 96,214,000 | -16,602,000 | -4,595,000 | 405,884,000 | 33,996,000 | 371,888,000 | 20,115,000 |
| Dec 2024 | 74,647,000 | -4,477,000 | -20,184,000 | 399,487,000 | 50,578,000 | 348,909,000 | 8,431,000 |
| Dec 2023 | 68,016,000 | -19,398,000 | -68,002,000 | 412,714,000 | 75,051,000 | 337,663,000 | -12,498,000 |
| Dec 2022 | 76,239,000 | -10,677,000 | -139,805,000 | 450,229,000 | 86,041,000 | 364,188,000 | -8,488,000 |
TTM Snapshot
Revenues TTM
$99,773,000
NetIncome TTM
$-2,961,000
OpCashFlow TTM
—
Assets (Latest)
$400,906,000
Forward EPS
$0.33
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $22.50 · spot: $38.61 · call volume: 14 · put volume: 2Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INSP | Inspire Medical Systems, Inc. | $1.93B | $66.69 | — |
| AXGN | Axogen, Inc. | $1.95B | $36.18 | — |
| LMAT | LEMAITRE VASCULAR INC | $1.82B | $79.64 | — |
| BFLY | Butterfly Network, Inc. | $1.97B | $8.03 | — |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | $1.81B | $60.61 | — |
News headlines (Yahoo Finance, 1h cache)
Why Freshworks Stock Bumped Higher Today
2026-10-06 22:13 · Yahoo
Repligen Completes Acquisition of BioLife Solutions
2026-10-06 13:05 · Yahoo
Freshworks stock climbs on S&P SmallCap 600 inclusion
2026-10-05 21:54 · Yahoo
BioLife Solutions Shareholders Approve Repligen Merger Agreement
2026-10-05 17:02 · Yahoo
This Long-Term Winning Stock Is in a Growth Market and Just Hit New 3-Year Highs
2026-09-24 15:10 · Yahoo
BioLife Solutions (BLFS) Is Up 7.2% After Swinging From Loss To Q2 Profit - What's Changed
2026-08-07 08:13 · Yahoo
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
2026-07-22 10:00 · Yahoo
Why Are Freshworks (FRSH) Shares Soaring Today
2026-10-06 20:48 · Yahoo
Diamond Hill Bets on BioLife Solutions’ (BLFS) High Switching Cost
2026-09-04 14:31 · Yahoo
Repligen (RGEN) Held An M&A Call With BioLife Solutions.
2026-07-28 20:12 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.